Document is current
Any future updates will be listed below
-
Authors
Burns, Andrew R. https://orcid.org/0000-0002-8966-1280
Baker, Rachel J. https://orcid.org/0000-0001-5514-8887
Kitner, Megan
Knox, Jessica https://orcid.org/0000-0003-1465-5852
Cooke, Brittany https://orcid.org/0000-0002-6386-1655
Volpatti, Jonathan R.
Vaidya, Aditya S.
Puumala, Emily https://orcid.org/0009-0008-3371-5877
Palmeira, Bruna M.
Redman, Elizabeth M.
Snider, Jamie https://orcid.org/0000-0001-5647-3729
Marwah, Sagar
Chung, Sai W.
MacDonald, Margaret H.
Tiefenbach, Jens https://orcid.org/0000-0003-4941-4477
Hu, Chun
Xiao, Qi
Finney, Constance A. M. https://orcid.org/0000-0002-8459-8462
Krause, Henry M. https://orcid.org/0000-0002-6182-7074
MacParland, Sonya A. https://orcid.org/0000-0002-8036-1425
Stagljar, Igor https://orcid.org/0000-0002-5260-3327
Gilleard, John S. https://orcid.org/0000-0002-6787-4699
Cowen, Leah E. https://orcid.org/0000-0001-5797-0110
Meyer, Susan L. F.
Cutler, Sean R. https://orcid.org/0000-0002-8593-0885
Dowling, James J. https://orcid.org/0000-0002-3984-4169
Lautens, Mark https://orcid.org/0000-0002-0179-2914
Zasada, Inga
Roy, Peter J. https://orcid.org/0000-0003-2959-2276
- License Information
-
More Information
Article History
Received: 18 May 2021
Accepted: 20 April 2023
First Online: 24 May 2023
Competing interests
: L.E.C. is a co-founder and shareholder in Bright Angel Therapeutics, a platform company for development of new antifungal therapeutics. L.E.C. is a consultant for Boragen, a small-molecule development company focused on leveraging the specific chemical properties of boron chemistry for crop protection and animal health. L.E.C. is a Science Advisor for Kapoose Creek, a company that harnesses the therapeutic potential of fungi. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture. USDA is an equal opportunity provider and employer. The University of Toronto is pursuing patent protection related to the use of selectivions as nematacides for which two national phase applications, US Patent Application 17/624,629, and Canadian Patent Application 3,146,085, are currently under prosecution and list A.R.B., M.L., R.B. and P.J.R. as inventors. A patent application, listing A.R.B., J.K., B.C., and P.J.R. as inventors, is under preparation for the use of yeast-based expression systems for the identification of bioactivated nematacides, insecticides, pesticides and drug leads. The patent application will be soon filed listing the inventors and the University of Toronto as applicants.
